Rituximab-induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti-rituximab antibodies.

Authors	Chiara Vendramin, Mari Thomas, John-Paul Westwood, Siobhan McGuckin, Marie Scully
Journal	British journal of haematology (Br J Haematol) Vol. 184 Issue 5 Pg. 858-861 (03 2019) ISSN: 1365-2141 [Electronic] England
PMID	29527657 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References	Antibodies Rituximab
Topics	Adult Antibodies (blood) Female Humans Middle Aged Purpura, Thrombotic Thrombocytopenic (blood, drug therapy) Rituximab (administration & dosage, adverse effects) Serum Sickness (blood, chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!